Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFIRE: Safety of Antimalarials in the First Trimester
PACTR202505891635396Phase 3Recruiting
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3 trial of dihydroartemisinin + piperaquine, artesunate + pyronaridine and artemether + lumefantrine in malaria, sponsored by Liverpool School of Tropical Medicine. Started May 2025; status: recruiting.
02
Drugs
dihydroartemisinin + piperaquineartesunate + pyronaridineartemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202505891635396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202505891635396.